Treatment of Medial Compartmental Osteoarthritis Grade 1-4 With TomoFix™ Small or Conservatively
NCT01048710
Arthritis, Bone Diseases
Toyama, Japan
View Trial DetailsNCT Number: NCT02077647
The primary objective of this registry is to assess the functional outcome measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS) for patients with medial unicompartmental osteoarthritis and osteonecrosis of the knee treated conservatively. The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study.
Looking for future studies?
Notify Me40 year and older
All sexes
Observational
Nagasaki University, Nagasaki, Japan
The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study.
The incidence of knee osteoarthritis (OA) is higher in Japan than in other populations. Respective prevalences of 47.0 and 70.2% in men and women for Kellgren-Lawrence Grades 2-4 knee OA are reported in Japanese patients aged 60 years and over.
First treatment options are pharmacological (i.e. NSAIDs) and non-pharmacological therapies (i.e. use of assistive devices, exercises, osteopathy, physical therapy), followed by injections of hyaluronic acid and other substances. If no such therapies are successful, surgical treatment options as unicompartmental knee replacement, total knee arthroplasty and high tibial osteotomy (HTO) are recognized. The discussion of which is the best therapy is still controversial. HTO may decrease the number of complications compared to total knee replacement or unicompartmental knee arthroplasty and leave the option for later replacement surgery.
In this project, patients are included who would be surgically treated with HTO with Tomofix small based on the investigator's assessment but refuse to have surgical treatment. They will be treated conservatively and are investigated to serve as reference to an ongoing clinical study investigating invasive treatment modalities.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 months
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time frame: 6 months, 12 months, 24 months
Oxford-12-item knee score, WOMAC (as calculated from the KOOS)
Time frame: 6 months, 12 months, 24 months
Japanese Orthopaedic Association (JOA) score
Time frame: 6 months, 12 months, 24 months
Short Form-36 (SF-36)
Time frame: 6 months, 12 months, 24 months
Time frame: 6 months, 12 months, 24 months
Visual Analogue Scale (VAS)
Time frame: 6 months, 12 months, 24 months
Time frame: 6 months, 12 months, 24 months
Time frame: up to hospital discharge
Length of hospital stay
Time frame: intraoperative and after 2 years
ICRS and Outerbridge / Koshino)
Time frame: 6 months, 12 months, 24 months
Kellgren-Lawrence classification, joint space narrowing, tibial slope, tibia vara
Time frame: 6 months, 12 months, 24 months
Complications due to injections, complications due to heat therapy, complications due to medication (NSAIDs)
Time frame: 6 months, 12 months, 24 months
Femoro tibial angle (FTA)
AO Clinical Investigation and Publishing Documentation
Other
A Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01048710
Arthritis, Bone Diseases
Toyama, Japan
View Trial DetailsNCT04910048
Arthritis, Arthritis, Rheumatoid
Little Rock, Arkansas, United States
View Trial DetailsNCT05787821
Arthritis, Arthritis, Rheumatoid
Parker, Colorado, United States
View Trial DetailsNCT03048201
Arthritis, Arthritis, Rheumatoid
Rancho Mirage, California, United States
View Trial Details